A Double-blind, Randomised, Placebo-controlled Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

Trial Profile

A Double-blind, Randomised, Placebo-controlled Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

Discontinued
Phase of Trial: Phase III

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Generalised seizures; Tonic-clonic epilepsy
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 27 Mar 2012 This trial has been completed in Germany as reported by European Clinical Trials Database record (Parent trial; EudraCT2007-003557-91).
    • 27 Mar 2012 This trial has been completed in Germany as reported by European Clinical Trials Database record (Parent trial; EudraCT2007-003557-91).
    • 24 Mar 2012 Planned patient number is 154 as reported by European Clinical Trials Database record (Extension trial; EudraCT2007-006695-10).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top